Evidence map›Paper›PMID 34042182›Full record

ReviewImmunology2021

Unknown/enigmatic functions of extracellular ASC.

Jean Gabriel de Souza, Nancy Starobinas, Olga Celia Martinez Ibañez

Open access · bronzeAbstract readReview
In one paragraph

Review in Immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Pharmacological targeting of adaptor proteins in chronic inflammation.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2024
    Review
  7. Article
  8. Nanomaterials Enhance Pyroptosis-Based Tumor Immunotherapy.International journal of nanomedicine · 2024
    Review
  9. Article
  10. Role of NLRP3 inflammasome-mediated neuronal pyroptosis and neuroinflammation in neurodegenerative diseases.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2023
    Review
  11. The NLRP3 inflammasome in viral infection (Review).Molecular medicine reports · 2023
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Frontiers in immunology · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Jean Gabriel de SouzaLaboratory of Immunogenetics, Butantan Institute, São Paulo, Brazil.ORCID 0000-0003-0618-7219
Nancy StarobinasLaboratory of Immunogenetics, Butantan Institute, São Paulo, Brazil.
Olga Celia Martinez IbañezLaboratory of Immunogenetics, Butantan Institute, São Paulo, Brazil.
Instituto Butantan · BRGlaxoSmithKline (United Kingdom) · GB

Funding

Fundação de Amparo à Pesquisa do Estado de São Paulo 2015/50040-4Fundação de Amparo à Pesquisa do Estado de São Paulo 2017/06736-0Fundação de Amparo à Pesquisa do Estado de São Paulo 2019/20713-8
6 · The paper itself

Abstract

Apoptosis-associated speck-like protein containing a caspase recruit domain (ASC), encoded by PYCARD gene, is a 22 kDa small molecule, which aggregates into ASC specks during inflammasome activation. ASC protein is an adaptor protein present in several inflammasome complexes that performs several intra- and extracellular functions, in monomeric form or as ASC specks, during physiological and pathological processes related to inflammation and adaptive immunity. Extracellular ASC specks (eASC specks) released during cell death by pyroptosis can contribute as a danger signal to the propagation of inflammation via phagocytosis and activation of surrounding cells. ASC specks are found in the circulation of patients with chronic inflammatory diseases and have been considered as relevant blood biomarkers of inflammation. eASC amplifies the inflammatory signal, may induce the production of autoantibodies, transports molecules that bind to this complex, contributing to the generation of antibodies, and can induce the maturation of cytokines promoting the modelling of the adaptive immunity. Although several advances have been registered in the last 21 years, there are numerous unknown or enigmatic gaps in the understanding of the role of eASC specks in the organism. Here, we provide an overview about the ASC protein focusing on the probable roles of eASC specks in several diseases, up to the most recent studies concerning COVID-19.

Indexed as

Adaptive ImmunityAlarminsAnimalsCARD Signaling Adaptor ProteinsCOVID-19Host-Pathogen InteractionsHumansInflammasomesInflammationInflammation MediatorsPhagocytosisPyroptosisSARS-CoV-2Signal TransductionAlarminsCARD Signaling Adaptor ProteinsInflammasomesInflammation MediatorsPYCARD protein, humanextracellular ASCinflammasomeinflammasome in COVID-19innate immunity

Identifiers

PMID34042182
PMCPMC8274145
OpenAlexW3180258564

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.